Small Molecule Inhibitors of Hepatitis C Virus

The invention provides derivatives and analogues of triazatetracyclo[7.7.0.01,13,.02,7]-hexadeca-2,4,6,10,12-pentaenes, 5,7,11-triazatetracyclo[8.7.0.01,6.012,17] -heptadeca- 6,8,12,14,16-pentaenes, pharmaceutical compositions comprising these compounds and methods for treatment of hepatitis C viral infections using these compounds.

Patents:
WO 2,011,056,630

Inventor(s): SNYDER JOHN K [US]; WEI WAN-GUO [US]; NI FENG [US]; STROSBERG ARTHUR DONNY [US]; KOTA SMITHA [US]; TAKAHASHI VIRGINIA [US]

Type of Offer: Licensing



« More Medical Patents

---